0001140361-15-031824.txt : 20150814 0001140361-15-031824.hdr.sgml : 20150814 20150814092946 ACCESSION NUMBER: 0001140361-15-031824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150813 FILED AS OF DATE: 20150814 DATE AS OF CHANGE: 20150814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOULWAN GEORGE A CENTRAL INDEX KEY: 0001222197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 151052880 4 1 doc1.xml FORM 4 X0306 4 2015-08-13 0 0001367644 Emergent BioSolutions Inc. EBS 0001222197 JOULWAN GEORGE A 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2015-08-13 4 M 0 7200 17.51 A 26700 D Common Stock 2015-08-13 4 S 0 7200 34.72 D 19500 D Common Stock 17.51 2015-08-13 4 M 0 7200 0 D 2020-07-16 Common Stock 7200 3600 D Consists of an option granted under the company's stock incentive plan on July 17, 2013. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.71 to $34.81, inclusive. The option vests in three equal installments in July 2014, 2015 and 2016. /s/ Eric Burt, attorney-in-fact 2015-08-14